Eden Rahim, portfolio manager and options strategist at Next Edge Capital says that as Canada waits for Pfizer to sort out logistics and expedite vaccine supply, the feds should rollout more serology testing to help identify groups among the population that already have stronger anti-bodies to COVID-19.